Melanocortin peptides
Three peptides that act on the same family of receptors. Two are FDA-approved medicines. One isn't.
Melanocortin receptors are found in several parts of the body. Depending on which one and where, they affect skin color, sexual function, appetite and inflammation. The three peptides here act on these receptors, and the differences between them are the point.
PT-141 (bremelanotide) is FDA-approved as Vyleesi, and afamelanotide as SCENESSE. Each has a dose on its label, a half-life measured in people (the time it takes for the level in the blood to halve), and safety information on the label. Melanotan II isn't FDA-approved. We found no half-life for it measured in people, and there are case reports of moles and other dark spots on the skin (pigmented lesions) changing in worrying ways.
Afamelanotide is the useful comparison, because it darkens skin, an effect Melanotan II is discussed for. It's approved for one narrow reason: to let adults who have had painful reactions to light from erythropoietic protoporphyria (EPP), a genetic condition that makes sunlight painful, spend more time in light without pain. It comes as a 16 mg implant that a healthcare professional places under the skin every two months. So this group does include an approved drug that darkens skin. Its approved use is EPP, not cosmetic tanning.
In this group
- PT-141 (Bremelanotide)An approved drug, with one fixed dose on its label.Approved by the FDA, as Vyleesi.
- Melanotan IIA tanning peptide that isn't FDA-approved, with case reports of moles changing quickly or in worrying ways.Not approved by the FDA.
- AfamelanotideAn approved implant that darkens skin, for a condition that makes sunlight painful.Approved by the FDA, as Scenesse, an implant placed by a clinician.
What we don't cover
These pages don't cover side effects, who shouldn't take them (contraindications), or drug interactions, with three exceptions. PT-141's page gives some of its label's safety information, including who shouldn't use it. Afamelanotide's page gives the warnings on its label. Melanotan II's page notes side effects and case reports from our sources.
Also in the library
Not among the 3 above. Each has its own page.
Get an early invite to Tidepath
The app isn't in the App Store yet. Leave your email for an early invite, and tips for your first month.
Get an early invite, tips and occasional news from Tidepath. Unsubscribe anytime. Privacy · Health data privacy · Sender and contact details